+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Middle East mRNA Synthesis Raw Material Market Forecast to 2033- Product Image
Middle East mRNA Synthesis Raw Material Market Forecast to 2033- Product Image
New

Middle East mRNA Synthesis Raw Material Market Forecast to 2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2025
  • Region: Middle East
  • Grand View Research
  • ID: 6189326
REQUEST CUSTOMIZATION
Description Jump to:
The Middle East mRNA synthesis raw material market size was valued at USD 51.8 million in 2024 and is expected to reach USD 77.3 million by 2033, expanding at a CAGR of 4.73% from 2025 to 2033. The market is driven by the increasing acceptance of mRNA-based therapeutics and vaccines, the expansion of biopharmaceutical manufacturing capacity, and the growing investment in genomic and molecular research in the region.

Rising adoption of mRNA-based vaccines And therapeutics

One of the main factors driving the growth of the mRNA synthesis raw material market is the increasing demand for mRNA-based vaccines and therapeutics. The historic performance of mRNA vaccines during the COVID-19 pandemic has confirmed the technological effectiveness documented in initial R&D efforts and the scalability and flexibility of mRNA "as a platform" to redefine modern medicine. This positive momentum in R&D activity generated demand for raw materials to prepare high-quality mRNA-associated products, with increased need for raw materials, such as nucleotides, capping reagents, enzymes, and lipid excipients, for mRNA synthesis and formulation.

Moreover, the increasing pipeline of mRNA therapeutics moving into clinical trials promotes long-term market growth. Governments and international health organizations are also supporting mRNA vaccine development programs to improve pandemic preparedness and fulfill other unmet medical needs. The expanding use of mRNA technologies for personalized and precision medicine, primarily in cancer immunotherapy, continues to generate ongoing demand for tailored, GMP-grade synthesis materials. Collectively, the common clinical acceptance of mRNA and diversification of its uses is becoming more evident as an important market component of next-generation therapeutic innovation.

Middle East mRNA Synthesis Raw Material Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, the analyst has segmented the Middle east mRNA synthesis raw material market on the basis of type, application, end-use, and country.

Type Outlook (Revenue, USD Million, 2021-2033)

  • Capping Agents
  • Nucleotides
  • Plasmid DNA
  • Enzymes
  • Others

Application Outlook (Revenue, USD Million, 2021-2033)

  • Vaccine Production
  • Therapeutics Production
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes

Country Outlook (Revenue, USD Million, 2021-2033)

  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman
  • Rest of Middle East

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Application Segment
1.2.3. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Middle East mRNA Synthesis Raw Materials Market Variables & Trends
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Advancements in mRNA technology
3.2.1.2. Rising adoption of mRNA-based vaccines and therapeutics
3.2.2. Market restraint analysis
3.3. Middle East mRNA Synthesis Raw Materials Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Middle East mRNA Synthesis Raw Materials Market: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. Middle East mRNA Synthesis Raw Materials Market Type Movement Analysis
4.3. Middle East mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Capping Agents
4.4.1. Capping agents market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. CleanCap Reagents
4.4.2.1. CleanCap reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. ARCA (Anti-Reverse Cap Analog)
4.4.3.1. ARCA (Anti-Reverse Cap Analog) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Nucleotides
4.5.1. Nucleotides market estimates and forecasts 2021 to 2033 (USD Million)
4.5.2. Modified nucleic acids
4.5.2.1. Modified nucleic acids market estimates and forecasts 2021 to 2033 (USD Million)
4.5.2.2. N1-methylpseudouridine-triphosphate
4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts 2021 to 2033 (USD Million)
4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts 2021 to 2033 (USD Million)
4.5.2.4. Others
4.5.2.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.5.3. Natural nucleic acids
4.5.3.1. Natural nucleic acids market estimates and forecasts 2021 to 2033 (USD Million)
4.5.3.2. Adenine
4.5.3.2.1. Adenine market estimates and forecasts 2021 to 2033 (USD Million)
4.5.3.3. Guanine
4.5.3.3.1. Guanine market estimates and forecasts 2021 to 2033 (USD Million)
4.5.3.4. Cytosine
4.5.3.4.1. Cytosine market estimates and forecasts 2021 to 2033 (USD Million)
4.5.3.5. Uracil
4.5.3.5.1. Uracil market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Plasmid DNA
4.6.1. Plasmid DNA market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Enzymes
4.7.1. Enzymes market estimates and forecasts 2021 to 2033 (USD Million)
4.7.2. Polymerase
4.7.2.1. Polymerase market estimates and forecasts 2021 to 2033 (USD Million)
4.7.3. RNase Inhibitor
4.7.3.1. RNase inhibitor market estimates and forecasts 2021 to 2033 (USD Million)
4.7.4. DNase
4.7.4.1. DNase market estimates and forecasts 2021 to 2033 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Middle East mRNA Synthesis Raw Materials Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Middle East mRNA Synthesis Raw Materials Market Application Movement Analysis
5.3. Middle East mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Vaccine Production
5.4.1. Vaccine production market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Therapeutics Production
5.5.1. Therapeutics production market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Middle East mRNA Synthesis Raw Materials Market: End Use Estimates & Trend Analysis
6.1. End Use Segment Dashboard
6.2. Middle East mRNA Synthesis Raw Materials Market End Use Movement Analysis
6.3. Middle East mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Biopharmaceutical & Pharmaceutical Companies
6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
6.5. CROs & CMOs
6.5.1. CROs & CMOs market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Academic & Research Institutes
6.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Middle East mRNA Synthesis Raw Material Market: Regional Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2023 & 2033
7.2. Country Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.4. Middle East
7.4.1. Saudi Arabia
7.4.1.1. Key country dynamics
7.4.1.2. Competitive scenario
7.4.1.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. UAE
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. Kuwait
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
7.4.4. Qatar
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
7.4.5. Oman
7.4.5.1. Key country dynamics
7.4.5.2. Competitive scenario
7.4.5.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
7.4.6. Rest of Middle East
7.4.6.1. Key country dynamics
7.4.6.2. Competitive scenario
7.4.6.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. F. Hoffmann-La Roche Ltd.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Service benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Jena Bioscience GmbH
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Service benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Merck KGaA
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Service benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Yeasen Biotechnology (Shanghai) Co., Ltd.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Service benchmarking
8.4.4.4. Strategic initiatives
8.4.5. BOC Sciences
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Service benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Thermo Fisher Scientific, Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Service benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Maravai LifeSciences
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Service benchmarking
8.4.7.4. Strategic initiatives
8.4.8. New England Biolabs
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Service benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Creative Biogene
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Service benchmarking
8.4.9.4. Strategic initiatives
8.4.10. HONGENE
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Service benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Middle East mRNA synthesis raw material market, by country, 2021-2033 (USD Million)
Table 3 Middle East mRNA synthesis raw material market, by type, 2021-2033 (USD Million)
Table 4 Middle East mRNA synthesis raw material market, by application, 2021-2033 (USD Million)
Table 5 Middle East mRNA synthesis raw material market, by end-use, 2021-2033 (USD Million)
Table 6 UAE Middle East mRNA synthesis raw materials market, by type, 2021-2033 (USD Million)
Table 7 UAE Middle East mRNA synthesis raw materials market, by application, 2021-2033 (USD Million)
Table 8 UAE Middle East mRNA synthesis raw materials market, by end-use, 2021-2033 (USD Million)
Table 9 Kuwait Middle East mRNA synthesis raw materials market, by type, 2021-2033 (USD Million)
Table 10 Kuwait Middle East mRNA synthesis raw materials market, by application, 2021-2033 (USD Million)
Table 11 Kuwait Middle East mRNA synthesis raw materials market, by end-use, 2021-2033 (USD Million)
Table 12 Qatar Middle East mRNA synthesis raw materials market, by type, 2021-2033 (USD Million)
Table 13 Qatar Middle East mRNA synthesis raw materials market, by application, 2021-2033 (USD Million)
Table 14 Qatar Middle East mRNA synthesis raw materials market, by end-use, 2021-2033 (USD Million)
Table 15 Oman Middle East mRNA synthesis raw materials market, by type, 2021-2033 (USD Million)
Table 16 Oman Middle East mRNA synthesis raw materials market, by application, 2021-2033 (USD Million)
Table 17 Oman Middle East mRNA synthesis raw materials market, by end-use, 2021-2033 (USD Million)
Table 18 Rest of Middle East mRNA synthesis raw material market, by type, 2021-2033 (USD Million)
Table 19 Rest of Middle East mRNA synthesis raw material market, by application, 2021-2033 (USD Million)
Table 20 Rest of Middle East mRNA synthesis raw material market, by end-use, 2021-2033 (USD Million)
List of Figures
Figure 1 Middle East mRNA synthesis raw materials market segmentation
Figure 2 Information procurement
Figure 3 Data analysis models
Figure 4 Market formulation and validation
Figure 5 Data validating & publishing
Figure 6 Market research process
Figure 7 Information procurement
Figure 8 Primary research
Figure 9 Market snapshot
Figure 10 Segment snapshot
Figure 11 Competitive landscape snapshot
Figure 12 Middle East mRNA synthesis raw materials market: Type outlook key takeaways
Figure 13 Middle East mRNA synthesis raw materials market: Type movement analysis
Figure 14 Capping agents market, 2021-2033 (USD Million)
Figure 15 CleanCap Reagents market, 2021-2033 (USD Million)
Figure 16 ARCA (Anti-Reverse Cap Analog) market, 2021-2033 (USD Million)
Figure 17 Others market, 2021-2033 (USD Million)
Figure 18 Nucleotides market, 2021-2033 (USD Million)
Figure 19 Modified Nucleic Acids market, 2021-2033 (USD Million)
Figure 20 N1-methylpseudouridine-triphosphate market, 2021-2033 (USD Million)
Figure 21 5-Methylcytidine triphosphate (5mCTP) market, 2021-2033 (USD Million)
Figure 22 Others market, 2021-2033 (USD Million)
Figure 23 Natural Nucleic Acids market, 2021-2033 (USD Million)
Figure 24 Adenine market, 2021-2033 (USD Million)
Figure 25 Guanine market, 2021-2033 (USD Million)
Figure 26 Cytosine market, 2021-2033 (USD Million)
Figure 27 Uracil market, 2021-2033 (USD Million)
Figure 28 Plasmid DNA market, 2021-2033 (USD Million)
Figure 29 Enzymes market, 2021-2033 (USD Million)
Figure 30 Polymerase market, 2021-2033 (USD Million)
Figure 31 RNase Inhibitor market, 2021-2033 (USD Million)
Figure 32 DNase market, 2021-2033 (USD Million)
Figure 33 Others market, 2021-2033 (USD Million)
Figure 34 Others market, 2021-2033 (USD Million)
Figure 35 Middle East mRNA synthesis raw materials market: Application outlook and key takeaways
Figure 36 Middle East mRNA synthesis raw materials market: Application movement analysis
Figure 37 Therapeutics production market, 2021-2033 (USD Million)
Figure 38 Vaccine production market, 2021-2033 (USD Million)
Figure 39 Other applications market, 2021-2033 (USD Million)
Figure 40 Middle East mRNA synthesis raw materials market: End-user outlook and key takeaways
Figure 41 Middle East mRNA synthesis raw materials market: End-user movement analysis
Figure 42 Biopharmaceutical & pharmaceutical companies market, 2021-2033 (USD Million)
Figure 43 CROs & CMOs market, 2021-2033 (USD Million)
Figure 44 Academic & research institutes market, 2021-2033 (USD Million)
Figure 45 Country marketplace outlook, 2023 & 2033 (USD Million)
Figure 46 Country marketplace: Key takeaways
Figure 47 Key country dynamics
Figure 48 Saudi Arabia Middle East mRNA synthesis raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Key country dynamics
Figure 50 UAE Middle East mRNA synthesis raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Key country dynamics
Figure 52 Kuwait Middle East mRNA synthesis raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Key country dynamics
Figure 54 Qatar Middle East mRNA synthesis raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Key country dynamics
Figure 56 Oman Middle East mRNA synthesis raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Rest of Middle East mRNA synthesis raw material market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 Market participant categorization
Figure 60 Strategic framework

Companies Mentioned

The companies profiled in this Middle East mRNA Synthesis Raw Material market report include:
  • F. Hoffmann-La Roche Ltd.
  • Jena Bioscience GmbH
  • Merck KGaA
  • Yeasen Biotechnology (Shanghai) Co., Ltd.
  • BOC Sciences
  • Thermo Fisher Scientific, Inc.
  • Maravai LifeSciences
  • New England Biolabs
  • Creative Biogene
  • HONGENE.

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 51.8 Million
Forecasted Market Value ( USD ) by 2033 $ 77.3 Million
Compound Annual Growth Rate4.7%
Regions CoveredMiddle East
No. of Companies Mentioned11

Related Topics

Related Reports

U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End Use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End Use, And Segment Forecasts, 2025 - 2033

  • Report
  • 90 Pages
  • United States
From
mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 170 Pages
  • Global
From
U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Indication (Infectious Diseases, Metabolic & Genetic Diseases), by Application, by End Use, and Segment Forecasts, 2025-2033 - Product Image

U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Indication (Infectious Diseases, Metabolic & Genetic Diseases), by Application, by End Use, and Segment Forecasts, 2025-2033

  • Report
  • 120 Pages
  • United States
From
mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Biologics Manufacturing Market Size, Share & Trends Analysis Report by Mode of Manufacturing (Contract, in-House), Modality, Disease Indication, and Region with Growth Forecasts, 2025-2033 - Product Image

Biologics Manufacturing Market Size, Share & Trends Analysis Report by Mode of Manufacturing (Contract, in-House), Modality, Disease Indication, and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.